This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Diabetes insipidus (cranial)

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

This is a rare condition caused by deficiency of ADH; over 90% of the neurons synthesizing vasopressin must be destroyed in order to produce ADH deficiency and cause polyuric symptoms (1). ADH can be detected in the plasma but at concentrations which are low for the plasma osmolality. Urine output ranges from 3-15 litres per 24 hours causing hypertonic dehydration and secondary polydipsia.

Adequate fluid intake permits most patients to achieve normonatraemia. Occasionally, hypothalamic disease may damage the thirst centre and/or the osmoreceptors resulting in hypernatraemia; this may also develop in patients denied access to water.

Be aware that the condition may be masked in patients with concomitant adrenocortical insufficiency as this impairs the ability of the kidney to excrete water. Features of CDI become apparent when corticosteroid replacement therapy is instigated.

References:

  1. Garrahy A, Moran C, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf). 2019 Jan;90(1):23-30. doi: 10.1111/cen.13866.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.